NOCTEVA AS
Operating
Forskning, utvikling, produksjon, lisensiering, kjøp og salg av
bioteknologiske produkter, tjenester og immaterielle rettigheter,
inkludert kliniske og pre-kliniske aktiviteter, samt virksomhet som
naturlig står i forbindelse med dette. Selskapet kan eie
aksjer/andeler i andre selskaper.
Medisinutvikling. Biomedisinsk oppdragsforskning.
Organization
- CEO
- MB
Magnar Bjørås1965
- Chairman of the board
- MB
Magnar Bjørås1965
- Years since formation
- 1 year
- since Jul 31, 2025
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 24
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 7
- persons
Financials
- Total operating income 2025
- 2,164,009
- NOK
- Annual total result 2025
- 118,369
- NOK
- Total equity 2025
- 6,291,869
- NOK
Last update: Oct 13, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
MB 1965 | Managing Director/CEO | 60 % directly |
Board
| Name | Role | Shares |
|---|---|---|
MB 1965 | Chairman | 60 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
MB 1965 | Managing Director/CEO, Chairman | 60 % directly |
JS | - | 12.5 % directly |
JY 1979 | - | 12.5 % directly |
WT 1980 | - | 5 % directly |
| - | 5 % directly | |
SA | - | 2.5 % directly |
MC | - | 2.5 % directly |
Last update: Sep 5, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
MB 1965 | Ordinary shares | 18,000 | 60 % |
JS | Ordinary shares | 3,750 | 12.5 % |
JY 1979 | Ordinary shares | 3,750 | 12.5 % |
| Ordinary shares | 1,500 | 5 % | |
WT 1980 | Ordinary shares | 1,500 | 5 % |
MC | Ordinary shares | 750 | 2.5 % |
SA | Ordinary shares | 750 | 2.5 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 |
|---|---|
Total operating income | 2,164,009 |
Annual Total Result | 118,369 |
Total assets | 15,003,467 |
Total liabilities | 8,711,599 |
Total equity | 6,291,869 |
P&L
| Year | 2025 |
|---|---|
Total operating income | 2,164,009 |
Total operating costs | 2,008,861 |
Operating result | 155,148 |
Financial income/costs | -5,226 |
Profit before tax | 149,922 |
Total tax & extraordinary income/cost | 31,553 |
Annual Total Result | 118,369 |
Balance overview
| Year | 2025 |
|---|---|
Total fixed assets | 6,030,016 |
Total current assets | 8,973,452 |
Total assets | 15,003,467 |
Short term debt | 8,680,046 |
Long term debt | 0 |
Total liabilities | 8,711,599 |
Contributed capital | 6,173,500 |
Retained earnings | 118,369 |
Total equity | 6,291,869 |
Total equity and liabilities | 15,003,467 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification